3,4,5-Trihydroxybenzoate

Details

Top
Internal ID 027db0f0-9c8b-402e-9326-f97766955e60
Taxonomy Benzenoids > Benzene and substituted derivatives > Benzoic acids and derivatives > Hydroxybenzoic acid derivatives > Gallic acid and derivatives
IUPAC Name 4-carboxy-2,6-dihydroxyphenolate
SMILES (Canonical) C1=C(C=C(C(=C1O)[O-])O)C(=O)O
SMILES (Isomeric) C1=C(C=C(C(=C1O)[O-])O)C(=O)O
InChI InChI=1S/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12)/p-1
InChI Key LNTHITQWFMADLM-UHFFFAOYSA-M
Popularity 12 references in papers

Physical and Chemical Properties

Top
Molecular Formula C7H5O5-
Molecular Weight 169.11 g/mol
Exact Mass 169.01369826 g/mol
Topological Polar Surface Area (TPSA) 101.00 Ų
XlogP 1.30
Atomic LogP (AlogP) -0.13
H-Bond Acceptor 4
H-Bond Donor 3
Rotatable Bonds 1

Synonyms

Top
pyrogallol-5-carboxylate
3,4,5-tris(oxidanyl)benzoate
CHEBI:16918
DTXSID90975374
5-Carboxy-2,3-dihydroxyphenolate
LNTHITQWFMADLM-UHFFFAOYSA-M
3,4,5-Trihydroxybenzoic acid ion
c0006
J3.617.291F
A808977
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 3,4,5-Trihydroxybenzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8128 81.28%
Caco-2 - 0.7776 77.76%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability + 0.6857 68.57%
Subcellular localzation Mitochondria 0.6484 64.84%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9434 94.34%
OATP1B3 inhibitior + 0.9290 92.90%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9857 98.57%
P-glycoprotein inhibitior - 0.9766 97.66%
P-glycoprotein substrate - 0.9924 99.24%
CYP3A4 substrate - 0.8169 81.69%
CYP2C9 substrate - 0.8086 80.86%
CYP2D6 substrate - 0.8832 88.32%
CYP3A4 inhibition - 0.8692 86.92%
CYP2C9 inhibition - 0.8096 80.96%
CYP2C19 inhibition - 0.9126 91.26%
CYP2D6 inhibition - 0.9590 95.90%
CYP1A2 inhibition - 0.9371 93.71%
CYP2C8 inhibition - 0.9520 95.20%
CYP inhibitory promiscuity - 0.9052 90.52%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.7923 79.23%
Carcinogenicity (trinary) Non-required 0.7732 77.32%
Eye corrosion - 0.8012 80.12%
Eye irritation + 0.9904 99.04%
Skin irritation + 0.8499 84.99%
Skin corrosion - 0.9202 92.02%
Ames mutagenesis - 0.8100 81.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8422 84.22%
Micronuclear + 0.8400 84.00%
Hepatotoxicity + 0.7750 77.50%
skin sensitisation + 0.7779 77.79%
Respiratory toxicity - 0.5444 54.44%
Reproductive toxicity + 0.7111 71.11%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity + 0.4613 46.13%
Acute Oral Toxicity (c) III 0.7088 70.88%
Estrogen receptor binding - 0.6796 67.96%
Androgen receptor binding + 0.6456 64.56%
Thyroid receptor binding - 0.8320 83.20%
Glucocorticoid receptor binding - 0.6234 62.34%
Aromatase binding - 0.7733 77.33%
PPAR gamma - 0.7479 74.79%
Honey bee toxicity - 0.9600 96.00%
Biodegradation + 0.9000 90.00%
Crustacea aquatic toxicity - 0.8400 84.00%
Fish aquatic toxicity + 0.9100 91.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3194 P02766 Transthyretin 91.95% 90.71%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.12% 95.56%
CHEMBL1811 P34995 Prostanoid EP1 receptor 87.03% 95.71%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.98% 91.11%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.02% 86.33%
CHEMBL4208 P20618 Proteasome component C5 82.90% 90.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.05% 99.17%

Cross-Links

Top
PubChem 54675821
NPASS NPC43696